TMX Newsfile

IN THE PRESS

Press Releases

OS Therapies Provides First Half 2026 Corporate Outlook

January 5, 2026

·

8 min read

Press Releases

TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026

January 2, 2026

·

9 min read

Press Releases

PharmaTher CEO Publishes Letter to Shareholders

January 2, 2026

·

7 min read

Press Releases

Izotropic Announces AGM Results

January 2, 2026

·

3 min read

Press Releases

Hemostemix Closes $480,000 Private Placement at $0.12 per Share

January 2, 2026

·

6 min read

Press Releases

TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

January 2, 2026

·

6 min read

Press Releases

BioMark: 2025 Achievements & 2026 Vision

January 2, 2026

·

7 min read

Press Releases

BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors

January 2, 2026

·

3 min read

Press Releases

CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways

January 2, 2026

·

4 min read

Press Releases

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

January 2, 2026

·

6 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750